A primary focus of the UCSF-GIVI CFAR is HIV-related research that is both translational andmultidisciplinary. The research often includes studies in which human subjects are the unit of observationand in whom complex biologic, behavioral, and clinical parameters are measured, often in a longitudinalmanner. A prerequisite of human subjects research is the direct interaction with and exemplarycharacterization of both diseased and non-diseased research subjects. As such, the overall objective of theClinical and Population Sciences Core will be to integrate the population sciences of epidemiology andbiostatistics with the clinical science of HIV medicine to facilitate the interaction with and characterization ofhuman subjects as well the analysis of the data and biological specimens derived from them. Fulfilling thisobjective in turn promotes multidisciplinary collaboration between laboratory-based and human subjectsbasedresearchers and is the sine qua non of translational research. Accordingly, the specific aims of theCore will be to support innovative human subjects-based HIV-related research by:1. Providing expertise in the Clinical and Population Sciences related to HIV/AIDS research via consultationregarding conception of research questions, study design, data management, biostatistical analysis, andinterpretation of data;2. Serving as the resource clearinghouse for CFAR investigators who seek to perform new analyses withavailable data in the many large San Francisco-based and national studies of HIV-infected and at-riskindividuals;3. Managing a unique prospective observational cohort of HIV-infected adults in the contemporary era thatprovides translational researchers with a diverse array of biological specimens from subjects who arewell-characterized in terms of clinical, behavioral, and epidemiologic parameters;4. Providing a platform for the efficient conduct of newly designed prospective human subjects studies;5. Mentoring junior investigators in the conduct of human subjects research.To achieve these aims, the Core will be directed by faculty with a wide range of experience in HIV-relatedresearch as well as methodological expertise in clinical research. In addition, the Core will serve as a link torelated institutional resources at UCSF for human subjects research, including those in the Center for AIDSPrevention Studies, the Division of Biostatistics, and the Training in Clinical Research program. By achievingan economy of scale in its services, the Core will provide resource-efficient, flexible, and timely support toCFAR members as they pursue emerging opportunities in human subjects-based HIV/AIDS research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027763-16
Application #
7278979
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2007-07-01
Project End
2012-08-31
Budget Start
2007-07-01
Budget End
2008-08-31
Support Year
16
Fiscal Year
2007
Total Cost
$404,808
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Pulugulla, Sree H; Packard, Thomas A; Galloway, Nicole L K et al. (2018) Distinct mechanisms regulate IL1B gene transcription in lymphoid CD4 T cells and monocytes. Cytokine 111:373-381
Mohamed, Tamer M A; Ang, Yen-Sin; Radzinsky, Ethan et al. (2018) Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration. Cell 173:104-116.e12
Chammartin, Frédérique; Zürcher, Kathrin; Keiser, Olivia et al. (2018) Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis. Clin Infect Dis 67:1643-1652
Vardi, Noam; Chaturvedi, Sonali; Weinberger, Leor S (2018) Feedback-mediated signal conversion promotes viral fitness. Proc Natl Acad Sci U S A 115:E8803-E8810
Carrico, Adam W; Flentje, Annesa; Kober, Kord et al. (2018) Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun 71:108-115
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Sauceda, John A; Lisha, Nadra E; Neilands, Torsten B et al. (2018) Cognitive-affective depressive symptoms and substance use among Latino and non-Latino White patients in HIV care: an analysis of the CFAR network of integrated clinical systems cohort. J Behav Med :
Carrico, Adam W; Cherenack, Emily M; Roach, Margaret E et al. (2018) Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS 32:767-771
Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin et al. (2018) HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Med 15:e1002534
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912

Showing the most recent 10 out of 1541 publications